Delivery Order SPE2DB20D9766-SPE2DB25FC1GA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,226.84 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order was awarded on September 8, 2025, with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge facility. The company has been registered in the...
- The Defense Logistics Agency awarded a $15,031.17 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 21, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be fulfilled at the contractor's facility in Park Ridge, Illinois, and represents a continuation of the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of October 1, 2025. This firm fixed-price delivery order was issued on September 10, 2025, without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. The company brings extensive...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,134.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. This delivery order, issued on August 27, 2025, with an ultimate completion date of September 18, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499.999 billion and valid through November...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract was awarded on September 19, 2025, with an ultimate completion date of October 10, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 30, 2025. This firm fixed-price delivery order was issued on September 9, 2025, with no set-aside designation applied. The order will be fulfilled from the awardee's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that serves as a critical supplier...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 Dose Vials with a ceiling value of $2,783.55. This firm fixed-price delivery order was awarded on September 5, 2025, with an ultimate completion date of September 26, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits within the broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $22,268.40 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials on August 15, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order represents a direct purchase from DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026. The contract carries no set-aside designation. DMS...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of August 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order employs firm fixed-price terms and represents a standard procurement action within the agency's pharmaceutical supply operations....
- The Defense Logistics Agency awarded a $16,701.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on June 17, 2025, for YF-VAX 1 dose vials with an ultimate completion date of July 10, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- SPE2DB20D9766Indefinite Delivery Contract
- SPE2DB20D9766-SPE2DB25FC1GADelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $22,268.40 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location with an ultimate completion date of September 12, 2025. This delivery order was awarded on August 21, 2025, without a set-aside designation, allowing the vendor to compete on an unrestricted basis. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.99 billion contract vehicle valid through November 2026. The IDC enables the agency to procure pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. YF-VAX, a yellow fever vaccine, represents one component of the extensive pharmaceutical portfolio the contractor supplies, which includes branded and generic prescription drugs, biologics, vaccines, and medical consumables across multiple therapeutic categories serving military health system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.3k | 8/21/25 |